VCG
Vantage Consulting Group’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,067
| Closed | -$18.3K | – | 231 |
|
|
2023
Q1 | $18.3K | Buy |
26,067
+14,316
| +122% | +$10.1K | 0.01% | 231 |
|
|
2022
Q4 | $26.6K | Buy |
+11,751
| New | +$26.6K | 0.02% | 211 |
|
|
2022
Q3 | – | Sell |
-10,673
| Closed | -$41K | – | 219 |
|
|
2022
Q2 | $41K | Buy |
+10,673
| New | +$41K | 0.02% | 212 |
|
|
2021
Q1 | – | Sell |
-1,098
| Closed | -$19K | – | 1049 |
|
|
2020
Q4 | $19K | Buy |
+1,098
| New | +$19K | ﹤0.01% | 901 |
|